Statistics
Publications
3
Citations
77
H-Index
3
Active since
2020
Magali Rebucci-Peixoto is an author at Centre Georges François Leclerc specializing in immune checkpoint inhibitors, checkpoint inhibitor therapy, and programmed cell death protein 1 (pd-1) pathway.
Publications per year
2020–2023
3
3
Magali Rebucci-Peixoto, Angélique Vienot, Olivier Adotévi et al. · Frontiers in Oncology · 2022 · 28 citations · Full text
Medicine, Immunology, Oncology +17
Stéfano Kim, Bruno Buecher, Thierry André et al. · BMC Cancer · 2020 · 27 citations · Full text
Medicine, Oncology, Pharmacology +17
Angélique Vienot, Marion Jacquin, Magali Rebucci-Peixoto et al. · BMC Cancer · 2023 · 22 citations · Full text
Life Sciences, Immunology, Oncology +17
1–3 of 3